We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. An updated algorithm for the Omnipod 5 automated insulin ...
The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet Corporation) since its launch in 2022. Omnipod 5, the only tubing-free pump ...
Users can note which content they would like to view more frequently. Instagram is handing users some control in deciding what content they see. The social media giant is allowing users to have a say ...
Instagram is introducing a new tool that lets you see and control your algorithm, starting with Reels, the company announced on Wednesday. The new tool, called “Your Algorithm,” lets you view the ...
What makes the news more interesting to me is how it follows Instagram’s launch of its Your Algorithm feature yesterday. Users will now see a list of what Instagram considers to be your top, recent ...
As was expected, on Thursday, OpenAI pushed out the latest update to its flagship AI model after CEO Sam Altman declared a “code red” within the company. The new release, GPT-5.2, is described by ...
The ChatGPT-maker is releasing its “best model yet” as it faces new pressures from Google and other AI competitors. OpenAI has introduced GPT-5.2, its smartest artificial intelligence model yet, with ...
OpenAI launched its latest frontier model, GPT-5.2, on Thursday amid increasing competition from Google, pitching it as its most advanced model yet and one designed for developers and everyday ...
On Thursday, OpenAI released GPT-5.2, its newest family of AI models for ChatGPT, in three versions called Instant, Thinking, and Pro. The release follows CEO Sam Altman’s internal “code red” memo ...
Dec 11 (Reuters) - OpenAI on Thursday launched its GPT-5.2 artificial intelligence model, after CEO Sam Altman reportedly issued an internal "code red" in early December pausing non‑core projects and ...
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results